US Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.

Press releases published on June 13, 2026

Virginia Family Chiropractic Provides VA-Accepted Drug-Free Pain Care in Woodbridge
Virginia Family Chiropractic Expands MLS Laser Therapy for Joint Pain in Manassas
Exclusive Fitness Marks 30 Years Serving Knoxville Health Community
Virginia Family Chiropractic Offers NeuroMed Nerve Therapy for Sciatica in Falls Church
Virginia Family Chiropractic Helps Alexandria Cancer Patients Regain Mobility With Shockwave Therapy
Falls Church Chiropractor Dr. Sarah Cassou Treats Whiplash With Drug-Free Cervical Curve Rehab
Alexandria Office Anchors Virginia Family Chiropractic's Widest Range of Pain Treatment Technology
Manassas Chiropractor Dr. Gyzel Tabrizi Uses Low-Force Instrument Adjusting for Joint and Back Pain
Woodbridge Chiropractors Use Graston Technique to Break Down Scar Tissue Behind Stubborn Pain
RefillGenie Now Offers Lab Orders on Demand
Physician Collaborators Connects Nurse Practitioners and Physician Assistants with Board-Certified Physicians in NJ
Natural Healing Center Sets Ethical Standard for Nutrition Response Testing®  Amid Industry Controversy
Heallexa Becomes One of the Largest Healthcare Directories With 6.3M Records
Boulder Crest Foundation Announces National PTG Day 2026 and Launch of Inside Posttraumatic Growth Podcast
Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism
HeroMD 4-MAX Claims Evaluated: Why Men Searching "Most Effective 4-in-1 Erectile Dysfunction Formula" Are Comparing SURGE, PRIME and The HERO System Explained
Why Property Owners Choose Fix Mold for Mold Testing, Mold Inspection, and Mold Remediation Services
Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease
 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

US Healthcare Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.